CIK 0001768224
- Accelerated filer
- Smaller reporting company
Arcturus Therapeutics Holdings Inc.
Sign in to watch- Ticker
- ARCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 858-900-2660
- Business address
- 10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
- 4 Planned sale Chief Scientific Officer & COO sold 5,000 shares at $27.16 ($135,800)
- 4 Planned sale Chief Scientific Officer & COO sold 25,000 shares at an average $30.08 ($751,902)
- 4 Planned sale Chief Scientific Officer & COO sold 5,000 shares at $25.93 ($129,650)
- 4 Open-market sale See Remarks sold 6,968 shares at $28.18 ($196,358)
- 4 Planned sale Chief Scientific Officer & COO sold 5,000 shares at $25.38 ($126,900)
- 4 Open-market sale Chief Scientific Officer & COO sold 5,000 shares at $16.07 ($80,350)
- 4 Open-market buy Director bought 2,222 shares at $18.00 ($39,996)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President and CEO bought 5,000 shares at $16.51 ($82,550)
- 4 Grant or award Chief Financial Officer acquired 1,068 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 8 · 149 filings